Universe Pharma sees 9.97% passive stake reported

Whitmore Limited and Chengming Tang filed a passive Schedule 13G showing shared voting and dispositive power over 499,424 UPC Class A shares (9.97%).

Rhea-AI Filing Summary

Universe Pharmaceuticals INC (UPC) received a Schedule 13G reporting passive ownership of its Class A ordinary shares by Whitmore Limited and Chengming Tang. Whitmore Limited, a British Virgin Islands company wholly owned and controlled by Chengming Tang, reports beneficial ownership of 499,424 Class A ordinary shares.

This position represents 9.97% of the Class A ordinary shares, based on 5,008,313 shares outstanding as of July 27, 2026. Both Whitmore Limited and Chengming Tang report shared voting and dispositive power over these 499,424 shares and no sole voting or dispositive power.

Key Figures

Shares beneficially owned: 499,424 Class A ordinary shares Percent of class: 9.97% Shares outstanding: 5,008,313 Class A ordinary shares +2 more

5 metrics

Shares beneficially owned 499,424 Class A ordinary shares Beneficially owned by Whitmore Limited and Chengming Tang

Percent of class 9.97% Ownership percentage of UPC Class A ordinary shares

Shares outstanding 5,008,313 Class A ordinary shares Shares outstanding as of July 27, 2026 used for percentage calculation

Shared voting power 499,424 shares Shared voting power for each reporting person

Shared dispositive power 499,424 shares Shared power to dispose for each reporting person

Key Terms

Schedule 13G, beneficially owned, shared voting power, shared dispositive power, +1 more

5 terms

Schedule 13G regulatory

"Whitmore Limited and Chengming Tang filed a Schedule 13G reporting ownership"

A Schedule 13G is a formal document that investors file with the government when they acquire a large ownership stake in a company, usually for investment purposes rather than control. It helps keep the public informed about who owns significant parts of a company's shares, which can influence how the company is managed and how investors make decisions. Filing this schedule is important for transparency and understanding the ownership landscape of publicly traded companies.

beneficially owned financial

"Amount beneficially owned: Whitmore Limited: 499,424.00 Chengming Tang: 499,424.00"

Beneficially owned describes securities or assets where a person has the economic rights and control—such as the right to receive dividends and to direct voting—even if legal title is held in another name. Think of it like having the keys and using a car that’s registered to someone else: you get the benefits and make decisions. Investors care because beneficial ownership reveals who truly controls value and voting power, affecting corporate decisions and takeover dynamics.

shared voting power financial

"Shared Voting Power 499,424.00"

Shared voting power occurs when two or more parties jointly have the right to vote or decide how a block of company shares is cast, like co-owners who must agree before moving a piece of furniture. Investors care because who controls voting rights affects board elections, major corporate decisions and takeover outcomes, and shared control can alter regulatory disclosures and the practical influence any holder has over a company’s direction and value.

shared dispositive power financial

"Shared Dispositive Power 499,424.00"

Class A ordinary shares financial

"Title of class of securities: Class A ordinary shares"

Class A ordinary shares are a type of ownership stake in a company that typically grants voting rights to shareholders, allowing them to have a say in important company decisions. They often come with priority in receiving dividends or profits, making them attractive to investors seeking influence and potential income. These shares help distinguish different levels of ownership and rights within a company's stock structure.

FAQ

What stake in UPC does Whitmore Limited report on this Schedule 13G?

Whitmore Limited reports beneficial ownership of 499,424 Class A ordinary shares of UPC, representing 9.97% of the class, based on 5,008,313 Class A ordinary shares outstanding as of July 27, 2026.

How much of UPC does Chengming Tang beneficially own according to the Schedule 13G?

Chengming Tang reports beneficial ownership of 499,424 Class A ordinary shares of UPC, or 9.97% of the class, through Whitmore Limited, which he wholly owns and controls.

Who has voting and dispositive power over the UPC shares reported on this Schedule 13G?

Whitmore Limited and Chengming Tang report shared voting power over 499,424 shares and shared dispositive power over 499,424 shares, with no sole voting or sole dispositive power over UPC shares.

What share count did UPC use to calculate ownership percentages on this Schedule 13G?

Ownership percentages were calculated based on 5,008,313 Class A ordinary shares outstanding as of July 27, 2026.

What is the relationship between Whitmore Limited and Chengming Tang in the UPC Schedule 13G?

Whitmore Limited is a British Virgin Islands company that is wholly owned and controlled by Chengming Tang. The 499,424 UPC Class A ordinary shares are held by Whitmore Limited and reported as beneficially owned by both reporting persons.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 09/01/2026 - 06:07 PM Accepted by SEC EDGAR 09/01/2026 - 06:07 PM Learn about SEC filing dates

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

Universe Pharmaceuticals INC

(Name of Issuer)

Class A ordinary shares

(Title of Class of Securities)

G9442G138

(CUSIP Number)

07/27/2026

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

Rule 13d-1(b)

Rule 13d-1(c)

Rule 13d-1(d)

schemaVersion:

SCHEDULE 13G

CUSIP Number(s): G9442G138

1

Names of Reporting Persons

Whitmore Limited

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

VIRGIN ISLANDS, BRITISH

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 499,424.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 499,424.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

499,424.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

9.97 %

12

Type of Reporting Person (See Instructions)

CO

Comment for Type of Reporting Person: The amount in rows 6, 8 and 9 represents 499,424 Class A ordinary shares held by Whitmore Limited, a company with limited liability formed in the British Virgin Islands. Whitmore Limited is wholly owned and controlled by Chengming Tang, an individual. Percentage of class is calculated based on 5,008,313 Class A ordinary shares outstanding as of July 27, 2026.

SCHEDULE 13G

CUSIP Number(s): G9442G138

1

Names of Reporting Persons

Chengming Tang

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

CHINA

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 499,424.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 499,424.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

499,424.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

9.97 %

12

Type of Reporting Person (See Instructions)

IN

Comment for Type of Reporting Person: The amount in rows 6, 8 and 9 represents 499,424 Class A ordinary shares held by Whitmore Limited, a company with limited liability formed in the British Virgin Islands. Whitmore Limited is wholly owned and controlled by Chengming Tang, an individual. Percentage of class is calculated based on 5,008,313 Class A ordinary shares outstanding as of July 27, 2026.

SCHEDULE 13G

Item 1.
(a)	Name of issuer: Universe Pharmaceuticals INC
(b)	Address of issuer's principal executive offices: 265 Jingjiu Avenue, Jinggangshan Economic and Technological, Ji'an, Jiangxi, CHINA, 343100
Item 2.
(a)	Name of person filing: Whitmore Limited Chengming Tang
(b)	Address or principal business office or, if none, residence: Whitmore Limited: Vistra Corporate Services Centre, Wickhams Cay II, Road Town, Tortola, British Virgin Islands Chengming Tang: Room 508, Block 20, Country Garden Kang Garden, Guangzhou, Guangdong Province 510000, People's Republic of China
(c)	Citizenship: Whitmore Limited: British Virgin Islands Chengming Tang: People's Republic of China
(d)	Title of class of securities: Class A ordinary shares
(e)	CUSIP Number(s): G9442G138
Item 3.	If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)	Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)	Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)	Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)	Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)	An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)	An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)	A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)	A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)	A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)	A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution:
(k)	Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.	Ownership
(a)	Amount beneficially owned: Whitmore Limited: 499,424.00 Chengming Tang: 499,424.00
(b)	Percent of class: Whitmore Limited: 9.97% Chengming Tang: 9.97%
(c)	Number of shares as to which the person has:
	(i) Sole power to vote or to direct the vote: See Row 5 of the cover page for each Reporting Person.
	(ii) Shared power to vote or to direct the vote: See Row 6 of the cover page for each Reporting Person.
	(iii) Sole power to dispose or to direct the disposition of: See Row 7 of the cover page for each Reporting Person.
	(iv) Shared power to dispose or to direct the disposition of: See Row 8 of the cover page for each Reporting Person.
Item 5.	Ownership of 5 Percent or Less of a Class.
	Not Applicable
Item 6.	Ownership of more than 5 Percent on Behalf of Another Person.
	Not Applicable
Item 7.	Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
	Not Applicable
Item 8.	Identification and Classification of Members of the Group.
	Not Applicable
Item 9.	Notice of Dissolution of Group.
	Not Applicable

Item 10.

Certifications:

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Whitmore Limited

Signature:	/s/ Chengming Tang
Name/Title:	Chengming Tang/Director
Date:	09/01/2026

Chengming Tang

Signature:	/s/ Chengming Tang
Name/Title:	Chengming Tang
Date:	09/01/2026

Exhibit Information

Exhibit 99.1 - Joint Filing Agreement